Drug Type Small molecule drug |
Synonyms CU 40101, CU-40101, CU40101 |
Target |
Action agonists |
Mechanism THR agonists(Thyroid hormone receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Androgenetic Alopecia | Phase 1 | China | 15 Aug 2022 |